Lung Cancer Staging: Clinical and Radiologic Perspectives

 

 Buy Article Permissions and Reprints

Abstract

Published in 2009, the 7th edition of the American Joint Committee on Cancer TNM staging system is the culmination of an extensive worldwide initiative to standardize and validate lung cancer staging. Unlike prior editions, the new staging system is now inclusive of small cell carcinoma and carcinoid tumors. In addition, significant changes were made to the T and M descriptors, resulting in improved prognostic stratification of disease. This review article highlights these changes, the rationale for their inclusion in the new staging manual, and the role of the radiologist in determining stage.

• References

• 1 http://www.lung.org/lung-disease/lung-cancer/resources/facts-figures/lung-cancer-fact-sheet.html . Accessed December 2012
  PubMed
• 2 http://www.surgeongeneral.gov/library/reports/smokingconsequences/index.html . Accessed December 2012
  PubMed
• 3 Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010; 78 (5–6) 289-301
  CrossrefPubMedGoogle Scholar
• 4 Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 2002; 20 (13) 2920-2929
  CrossrefPubMedGoogle Scholar
• 5 Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569
  CrossrefPubMedGoogle Scholar
• 6 Yang P, Allen MS, Aubry MC , et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005; 128 (1) 452-462
  CrossrefPubMedGoogle Scholar
• 7 Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83 (5) 584-594
  CrossrefPubMedGoogle Scholar
• 8 Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005; 366 (9494) 1385-1396
  CrossrefPubMedGoogle Scholar
• 9 UyBico SJ, Wu CC, Suh RD, Le NH, Brown K, Krishnam MS. Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. Radiographics 2010; 30 (5) 1163-1181
  CrossrefPubMedGoogle Scholar
• 10 Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH. The process for continuous improvement of the TNM classification. Cancer 2004; 100 (1) 1-5
  CrossrefPubMedGoogle Scholar
• 11 Mountain CF, Carr DT, Anderson WA. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med 1974; 120 (1) 130-138
  CrossrefPubMedGoogle Scholar
• 12 Mountain CF. The new International Staging System for Lung Cancer. Surg Clin North Am 1987; 67 (5) 925-935
  PubMedGoogle Scholar
• 13 Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111 (6) 1710-1717
  CrossrefPubMedGoogle Scholar
• 14 Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol 2006; 1 (4) 281-286
  CrossrefPubMedGoogle Scholar
• 15 Groome PA, Bolejack V, Crowley JJ , et al; IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2 (8) 694-705
  CrossrefPubMedGoogle Scholar
• 16 Rami-Porta R, Ball D, Crowley J , et al; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2 (7) 593-602
  CrossrefPubMedGoogle Scholar
• 17 Goldstraw P, Crowley J, Chansky K , et al; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2 (8) 706-714
  CrossrefPubMedGoogle Scholar
• 18 Shepherd FA, Crowley J, Van Houtte P , et al; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2 (12) 1067-1077
  CrossrefPubMedGoogle Scholar
• 19 Ignatius Ou SH, Zell JA. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition. J Thorac Oncol 2009; 4 (3) 300-310
  CrossrefPubMedGoogle Scholar
• 20 Vallières E, Shepherd FA, Crowley J , et al; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4 (9) 1049-1059
  CrossrefPubMedGoogle Scholar
• 21 Postmus PE, Brambilla E, Chansky K , et al; International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2 (8) 686-693
  CrossrefPubMedGoogle Scholar
• 22 Rusch VW, Crowley J, Giroux DJ , et al; International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2 (7) 603-612
  CrossrefPubMedGoogle Scholar
• 23 Chien CR, Yang ST, Chen CY , et al. Impact of the new lung cancer staging system for a predominantly advanced-disease patient population. J Thorac Oncol 2010; 5 (3) 340-343
  CrossrefPubMedGoogle Scholar
• 24 Boffa DJ, Detterbeck FC, Smith EJ , et al. Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?. J Thorac Oncol 2010; 5 (11) 1779-1783
  CrossrefPubMedGoogle Scholar
• 25 Strand TE, Rostad H, Wentzel-Larsen T, von Plessen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J 2010; 36 (2) 401-407
  CrossrefPubMedGoogle Scholar
• 26 Travis WD, Giroux DJ, Chansky K , et al; International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2008; 3 (11) 1213-1223
  CrossrefPubMedGoogle Scholar
• 27 Marshall HM, Leong SC, Bowman RV, Yang IA, Fong KM. The science behind the 7th edition Tumour, Node, Metastasis staging system for lung cancer. Respirology 2012; 17 (2) 247-260
  CrossrefPubMedGoogle Scholar
• 28 Travis WD, Brambilla E, Rami-Porta R , et al; International Staging Committee. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008; 3 (12) 1384-1390
  CrossrefPubMedGoogle Scholar
• 29 Edge SB. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: xiv
  Google Scholar
• 30 Ou SH, Zell JA. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008; 3 (3) 216-227
  CrossrefPubMedGoogle Scholar
• 31 Watanabe S, Ladas G, Goldstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Ann Thorac Surg 2002; 73 (1) 245-248 ; discussion 248–249
  CrossrefPubMedGoogle Scholar
• 32 Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4 (5) 568-577
  CrossrefPubMedGoogle Scholar
• 33 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76 (6) 832-839
  PubMedGoogle Scholar
• 34 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111 (6) 1718-1723
  CrossrefPubMedGoogle Scholar
• 35 Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 7th ed. Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell; 2010: xx
  Google Scholar
• 36 Travis WD, Brambilla E, Noguchi M , et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6 (2) 244-285
  CrossrefPubMedGoogle Scholar
• 37 Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253 (3) 606-622
  CrossrefPubMedGoogle Scholar
• 38 Nakazono T, Sakao Y, Yamaguchi K, Imai S, Kumazoe H, Kudo S. Subtypes of peripheral adenocarcinoma of the lung: differentiation by thin-section CT. Eur Radiol 2005; 15 (8) 1563-1568
  CrossrefPubMedGoogle Scholar
• 39 Kojima Y, Saito H, Sakuma Y , et al. Correlations of thin-section computed tomographic, histopathological, and clinical findings of adenocarcinoma with a bubblelike appearance. J Comput Assist Tomogr 2010; 34 (3) 413-417
  CrossrefPubMedGoogle Scholar
• 40 Ikehara M, Saito H, Kondo T , et al. Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findings. Eur J Radiol 2012; 81 (1) 189-194
  CrossrefPubMedGoogle Scholar
• 41 Takashima S, Maruyama Y, Hasegawa M, Saito A, Haniuda M, Kadoya M. High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 2003; 70 (1) 36-42
  CrossrefPubMedGoogle Scholar
• 42 Austin JH, Garg K, Aberle D , et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology 2013; 266 (1) 62-71
  CrossrefPubMedGoogle Scholar
• 43 Ohtaki Y, Yoshida J, Ishii G , et al. Prognostic significance of a solid component in pulmonary adenocarcinoma. Ann Thorac Surg 2011; 91 (4) 1051-1057
  CrossrefPubMedGoogle Scholar
• 44 Lampen-Sachar K, Zhao B, Zheng J , et al. Correlation between tumor measurement on computed tomography and resected specimen size in lung adenocarcinomas. Lung Cancer 2012; 75 (3) 332-335
  CrossrefPubMedGoogle Scholar
• 45 Cetinkaya E, Turna A, Yildiz P , et al. Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. Eur J Cardiothorac Surg 2002; 22 (6) 1000-1005
  CrossrefPubMedGoogle Scholar
• 46 Travis WD, Brambilla E, Noguchi M , et al; American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011; 8 (5) 381-385
  CrossrefPubMedGoogle Scholar
• 47 Glazer HS, Duncan-Meyer J, Aronberg DJ, Moran JF, Levitt RG, Sagel SS. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985; 157 (1) 191-194
  PubMedGoogle Scholar
• 48 Webb WR, Gatsonis C, Zerhouni EA , et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178 (3) 705-713
  CrossrefPubMedGoogle Scholar
• 49 Quint LE, Francis IR. Radiologic staging of lung cancer. J Thorac Imaging 1999; 14 (4) 235-246
  CrossrefPubMedGoogle Scholar
• 50 Glazer HS, Kaiser LR, Anderson DJ , et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 1989; 173 (1) 37-42
  PubMedGoogle Scholar
• 51 Grover FL. The role of CT and MRI in staging of the mediastinum. Chest 1994; 106 (6, Suppl): 391S-396S
  CrossrefPubMedGoogle Scholar
• 52 Hierholzer J, Luo L, Bittner RC , et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118 (3) 604-609
  CrossrefPubMedGoogle Scholar
• 53 O'Sullivan P, O'Dwyer H, Flint J, Munk PL, Muller NL. Malignant chest wall neoplasms of bone and cartilage: a pictorial review of CT and MR findings. Br J Radiol 2007; 80 (956) 678-684
  CrossrefPubMedGoogle Scholar
• 54 McLoud TC, Bourgouin PM, Greenberg RW , et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182 (2) 319-323
  CrossrefPubMedGoogle Scholar
• 55 Kim HY, Yi CA, Lee KS , et al. Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging. Radiology 2008; 246 (2) 596-604
  CrossrefPubMedGoogle Scholar
• 56 Silvestri GA, Gould MK, Margolis ML , et al; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): 178S-201S
  CrossrefPubMedGoogle Scholar
• 57 Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 2000; 117 (3) 773-778
  CrossrefPubMedGoogle Scholar
• 58 Marom EM, McAdams HP, Erasmus JJ , et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212 (3) 803-809
  CrossrefPubMedGoogle Scholar
• 59 Pieterman RM, van Putten JW, Meuzelaar JJ , et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343 (4) 254-261
  CrossrefPubMedGoogle Scholar
• 60 Antoch G, Stattaus J, Nemat AT , et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229 (2) 526-533
  CrossrefPubMedGoogle Scholar
• 61 Lardinois D, Weder W, Hany TF , et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348 (25) 2500-2507
  CrossrefPubMedGoogle Scholar
• 62 Steinert HC, Hauser M, Allemann F , et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202 (2) 441-446
  PubMedGoogle Scholar
• 63 Roberts PF, Follette DM, von Haag D , et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70 (4) 1154-1159 ; discussion 1159–1160
  CrossrefPubMedGoogle Scholar
• 64 Giroux DJ, Rami-Porta R, Chansky K , et al; International Association for the Study of Lung Cancer International Staging Committee. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J Thorac Oncol 2009; 4 (6) 679-683
  CrossrefPubMedGoogle Scholar
• 65 Grimm J, Kirsch DG, Windsor SD , et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A 2005; 102 (40) 14404-14409
  CrossrefPubMedGoogle Scholar
• 66 McWilliams A, MacAulay C, Gazdar AF, Lam S. Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions. Oncogene 2002; 21 (45) 6949-6959
  CrossrefPubMedGoogle Scholar
• 67 Pelosi G. The new taxonomy of lung adenocarcinoma stemming from a multidisciplinary integrated approach: novel pathology concepts and perspectives. J Thorac Oncol 2011; 6 (2) 241-243
  CrossrefPubMedGoogle Scholar
• 68 Lencioni R, Crocetti L, Cioni R , et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (7) 621-628
  CrossrefPubMedGoogle Scholar